Ankylosing spondylitis and comorbidity: safety of long-term use of nimesulide
Ankylosing spondylitis (AS) is a socially significant rheumatic disease that generally starts in young adults and, if untreated, often leads to temporary incapacitation, and by 40 years, and to disability. Despite the relatively young age of patients, the course of AS is accompanied by a number of c...
Main Author: | R. M. Balabanova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2018-01-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/799 |
Similar Items
-
Pain is a major component of quality of life in patients with ankylosing spondylitis and the possibilities of its relief
by: Oksana Anatolyevna Pirogova, et al.
Published: (2013-10-01) -
Combination use of anti-inflammatory drugs and myorelaxants in the treatment of patients with ankylosing spondylitis in outpatient settings
by: Inna Zurabievna Gaidukova, et al.
Published: (2015-09-01) -
Investigating the genetics and immunopathogenesis of ankylosing spondylitis
by: Liu, F
Published: (2024) -
Safety and Clinical Response in Ankylosing Spondylitis after Three Months of Etanercept Therapy
by: Roshaan Tahir, et al.
Published: (2024-08-01) -
OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Elena Efimovna Gubar, et al.
Published: (2013-12-01)